sunresin(SZ:300487) ZHONGTAI SECURITIES·2025-10-28 13:03Investment Rating - The investment rating for the company is "Buy" (maintained) [1][17]. Core Views - The company has shown steady performance with a focus on high-margin segments, particularly in life sciences and metal resources, which are expected to drive future growth [3][12]. - The company reported a revenue of 1.933 billion yuan for Q3 2025, reflecting a year-on-year increase of 2.20%, and a net profit of 652 million yuan, up 9.27% year-on-year [3][6]. - The gross margin for the first three quarters of 2025 was 52.81%, an increase of 4.16 percentage points year-on-year, driven by a higher proportion of high-margin products and a decline in raw material prices [3][6]. Summary by Relevant Sections Financial Performance - For 2023, the company achieved a revenue of 2.489 billion yuan, with a year-on-year growth rate of 30%. The projected revenue for 2024 is 2.554 billion yuan, with a growth rate of 3% [1]. - The net profit for 2023 was 717 million yuan, with a year-on-year growth of 33%. The forecast for 2024 is a net profit of 787 million yuan, reflecting a growth of 10% [1]. - The earnings per share (EPS) for 2023 was 1.41 yuan, projected to increase to 1.55 yuan in 2024 [1]. Business Segments - The core business segments include ultra-pure water, life sciences, and metal resources, all of which are maintaining growth trends [3]. - The ultra-pure water segment is expected to generate over 500 million yuan in revenue for Q1-Q3 2025, with a year-on-year growth of over 8% [3]. - The life sciences segment is projected to exceed 450 million yuan in revenue for Q1-Q3 2025, with a year-on-year growth of over 10% [3]. - The metal resources segment is anticipated to generate over 200 million yuan in revenue for Q1-Q3 2025, with a year-on-year growth of over 25% [3]. Valuation Metrics - The price-to-earnings (P/E) ratio is projected to decrease from 40.4 in 2023 to 30.4 in 2025, indicating an improving valuation as earnings grow [1]. - The price-to-book (P/B) ratio is expected to decline from 8.4 in 2023 to 6.0 in 2025, reflecting a strengthening financial position [1]. Future Outlook - The company is expected to achieve net profits of 953 million yuan in 2025, 1.169 billion yuan in 2026, and 1.423 billion yuan in 2027, with corresponding P/E ratios of 30.4, 24.8, and 20.3 [3][12]. - The company is focusing on the industrialization of adsorption separation technology and the localization of life science materials, which are expected to contribute to strong growth [3].